BORCS7
gene geneOn this page
Also known as FLJ40752
Summary
BORCS7 (BLOC-1 related complex subunit 7, HGNC:23516) is a protein-coding gene on chromosome 10q24.32, encoding BLOC-1-related complex subunit 7 (Q96B45). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery.
Predicted to be involved in organelle transport along microtubule; regulation of endosome size; and regulation of lysosome size. Predicted to act upstream of or within several processes, including lysosome localization; motor behavior; and response to cycloheximide. Part of BORC complex.
Source: NCBI Gene 119032 — RefSeq curated summary.
At a glance
- GWAS associations: 25
- Clinical variants (ClinVar): 17 total
- MANE Select transcript:
NM_001136200
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23516 |
| Approved symbol | BORCS7 |
| Name | BLOC-1 related complex subunit 7 |
| Location | 10q24.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40752 |
| Ensembl gene | ENSG00000166275 |
| Ensembl biotype | protein_coding |
| OMIM | 616600 |
| Entrez | 119032 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000339834, ENST00000369883, ENST00000478833, ENST00000878900
RefSeq mRNA: 2 — MANE Select: NM_001136200
NM_001136200, NM_144591
CCDS: CCDS7542
Canonical transcript exons
ENST00000339834 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001432461 | 102862873 | 102864961 |
| ENSE00001846473 | 102854259 | 102854427 |
| ENSE00003481243 | 102860332 | 102860394 |
| ENSE00003549423 | 102860498 | 102860541 |
| ENSE00003566433 | 102862160 | 102862180 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 96.56.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0880 / max 22.1598, expressed in 800 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 106774 | 21.0684 | 1802 |
| 106773 | 1.0880 | 800 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 96.56 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.48 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.26 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 96.19 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.77 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.65 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 95.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.59 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.56 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.52 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.43 | gold quality |
| adrenal cortex | UBERON:0001235 | 95.34 | gold quality |
| parietal pleura | UBERON:0002400 | 95.25 | gold quality |
| bronchus | UBERON:0002185 | 95.02 | gold quality |
| adrenal gland | UBERON:0002369 | 94.98 | gold quality |
| endothelial cell | CL:0000115 | 94.72 | gold quality |
| tibialis anterior | UBERON:0001385 | 94.23 | gold quality |
| deltoid | UBERON:0001476 | 94.16 | gold quality |
| tibia | UBERON:0000979 | 93.83 | gold quality |
| ileal mucosa | UBERON:0000331 | 93.72 | gold quality |
| skin of hip | UBERON:0001554 | 93.11 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 93.11 | gold quality |
| visceral pleura | UBERON:0002401 | 93.10 | gold quality |
| upper arm skin | UBERON:0004263 | 93.05 | gold quality |
| quadriceps femoris | UBERON:0001377 | 92.99 | gold quality |
| myocardium | UBERON:0002349 | 92.88 | gold quality |
| vastus lateralis | UBERON:0001379 | 92.73 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 92.72 | gold quality |
| superficial temporal artery | UBERON:0001614 | 92.43 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.29 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-88 | yes | 19.36 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
63 targeting BORCS7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-8075 | 99.97 | 67.20 | 962 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-219A-5P | 99.91 | 73.36 | 735 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-4782-3P | 99.88 | 73.31 | 735 |
| HSA-MIR-6766-3P | 99.88 | 73.38 | 732 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
Literature-anchored findings (GeneRIF, showing 5)
- this study implicates altered neural expression of BORCS7, AS3MT, and NT5C2 in susceptibility to schizophrenia arising from genetic variation at the chromosome 10q24 locus (PMID:27004590)
- Risk alleles spanning multiple genes across the 10q24.32 schizophrenia-related locus are associated in the human brain selectively with an increase in the expression of both BLOC-1 related complex subunit 7 (BORCS7) and a previously uncharacterized, human-specific arsenite methyltransferase (AS3MT) isoform (AS3MTd2d3). (PMID:27158905)
- Sngle nucleotide polymorphism in c10orf32 gene is associated with skin lesions. (PMID:27692299)
- effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: a PET imaging study (PMID:31386983)
- BORC complex specific components and Kinesin-1 mediate autophagy evasion by the autophagy-resistant Mycobacterium tuberculosis Beijing strain. (PMID:36717601)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | borcs7 | ENSDARG00000055070 |
| mus_musculus | Borcs7 | ENSMUSG00000062376 |
| rattus_norvegicus | Borcs7 | ENSRNOG00000073762 |
| drosophila_melanogaster | BORCS7 | FBGN0034519 |
| caenorhabditis_elegans | WBGENE00010981 |
Protein
Protein identifiers
BLOC-1-related complex subunit 7 — Q96B45 (reviewed: Q96B45)
Alternative names: Diaskedin
All UniProt accessions (1): Q96B45
UniProt curated annotations — full annotation on UniProt →
Function. As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor.
Subunit / interactions. Component of the BLOC-one-related complex (BORC) which is composed of BLOC1S1, BLOC1S2, BORCS5, BORCS6, BORCS7, BORCS8, KXD1 and SNAPIN.
Subcellular location. Lysosome membrane.
Miscellaneous. Diaskedin is from the ancient Greek diaskedazo, meaning to disperse.
Similarity. Belongs to the BORCS7 family.
RefSeq proteins (2): NP_001129672, NP_653192 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032143 | BORCS7 | Family |
Pfam: PF16088
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96B45-F1 | 94.84 | 0.90 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 146 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_BEHAVIOR, GOCC_VACUOLAR_MEMBRANE, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOBP_NEUROGENESIS, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE, GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_RESPONSE_TO_KETONE, GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_CELL_PROJECTION_ORGANIZATION
GO Biological Process (10): vesicle-mediated transport (GO:0016192), lysosome localization (GO:0032418), response to cycloheximide (GO:0046898), neuromuscular process (GO:0050905), regulation of endosome size (GO:0051036), axon development (GO:0061564), motor behavior (GO:0061744), regulation of lysosome size (GO:0062196), organelle transport along microtubule (GO:0072384), walking behavior (GO:0090659)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): cytoplasmic side of lysosomal membrane (GO:0098574), BORC complex (GO:0099078), lysosome (GO:0005764), lysosomal membrane (GO:0005765), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 1 |
| cellular process | 1 |
| vacuolar localization | 1 |
| response to alcohol | 1 |
| response to ketone | 1 |
| response to nitrogen compound | 1 |
| nervous system process | 1 |
| regulation of vesicle size | 1 |
| neuron projection development | 1 |
| behavior | 1 |
| regulation of cellular component size | 1 |
| transport along microtubule | 1 |
| establishment of organelle localization | 1 |
| locomotory behavior | 1 |
| binding | 1 |
| lysosomal membrane | 1 |
| cytoplasmic side of membrane | 1 |
| intracellular protein-containing complex | 1 |
| lytic vacuole | 1 |
| lysosome | 1 |
| lytic vacuole membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
436 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BORCS7 | BORCS5 | Q969J3 | 990 |
| BORCS7 | BORCS6 | Q96GS4 | 988 |
| BORCS7 | BLOC1S2 | Q6QNY1 | 987 |
| BORCS7 | KXD1 | Q9BQD3 | 987 |
| BORCS7 | SNAPIN | O95295 | 984 |
| BORCS7 | BORCS8 | Q96FH0 | 968 |
| BORCS7 | BLOC1S1 | P78537 | 966 |
| BORCS7 | AS3MT | Q9HBK9 | 798 |
| BORCS7 | ARL8B | Q9NVJ2 | 618 |
| BORCS7 | CNNM2 | Q9H8M5 | 607 |
| BORCS7 | ARL5B | Q96KC2 | 596 |
| BORCS7 | NT5C2 | P49902 | 580 |
| BORCS7 | WBP1L | Q9NX94 | 574 |
| BORCS7 | ARL8A | Q96BM9 | 556 |
| BORCS7 | U3KPZ7 | U3KPZ7 | 540 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LAMTOR4 | LAMTOR5 | psi-mi:“MI:0914”(association) | 0.960 |
| LAMTOR1 | LAMTOR5 | psi-mi:“MI:0914”(association) | 0.870 |
| PRPF19 | PLRG1 | psi-mi:“MI:0914”(association) | 0.770 |
| IKBIP | SNAPIN | psi-mi:“MI:0914”(association) | 0.670 |
| BORCS6 | HSBP1 | psi-mi:“MI:0914”(association) | 0.530 |
| BORCS8 | SNAPIN | psi-mi:“MI:0914”(association) | 0.530 |
| KXD1 | HIP1 | psi-mi:“MI:0914”(association) | 0.530 |
| WLS | BORCS7 | psi-mi:“MI:0915”(physical association) | 0.490 |
| TEX35 | SNAPIN | psi-mi:“MI:0914”(association) | 0.350 |
| SHANK3 | IGKV3D-15 | psi-mi:“MI:0914”(association) | 0.350 |
| LAMTOR2 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| PIP4P1 | SCAMP1 | psi-mi:“MI:0914”(association) | 0.350 |
| VRK1 | LAMTOR5 | psi-mi:“MI:0914”(association) | 0.350 |
| KRT27 | CCDC88B | psi-mi:“MI:0914”(association) | 0.350 |
| INSYN1 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| WHAMMP3 | EXOC5 | psi-mi:“MI:0914”(association) | 0.350 |
| LAMTOR5 | ERI3 | psi-mi:“MI:0914”(association) | 0.350 |
| BRK1 | KIF5C | psi-mi:“MI:0914”(association) | 0.350 |
| BLOC1S6 | HSBP1 | psi-mi:“MI:0914”(association) | 0.350 |
| BORCS7 | SNAPIN | psi-mi:“MI:0914”(association) | 0.350 |
| MYPOP | SNAPIN | psi-mi:“MI:0914”(association) | 0.350 |
| BORCS8 | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| BORCS6 | UQCRQ | psi-mi:“MI:0914”(association) | 0.350 |
| BLOC1S6 | KCNN4 | psi-mi:“MI:0914”(association) | 0.350 |
| BCAS4 | SNAPIN | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (57): C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Proximity Label-MS), LOH12CR1 (Affinity Capture-MS), LAMTOR1 (Affinity Capture-MS), SNAPIN (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), C10orf32 (Affinity Capture-MS), BLOC1S1 (Affinity Capture-MS)
ESM2 similar proteins: A1JU78, A1XIQ0, A3KQI3, A6NF36, A8MTZ0, O17213, O36384, O57414, O74982, P03758, P0C2N4, P11500, P11924, P11925, P14268, P16420, P59636, P61416, P68968, P68969, P83175, Q01010, Q05127, Q09410, Q1PD52, Q28I03, Q29S20, Q2KIB7, Q32L75, Q39236, Q3E744, Q4V8S9, Q5H943, Q5RE16, Q61585, Q67616, Q6V1Q9, Q6X4T0, Q80956, Q8BGD0
Diamond homologs: Q28DH3, Q2KIB7, Q4V8S9, Q5REK7, Q96B45, Q9CRC6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 40 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| lysosome localization | 6 | 92.9× | 1e-08 |
| positive regulation of TORC1 signaling | 5 | 43.5× | 4e-06 |
| protein transport | 6 | 7.7× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 16 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
792 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:102854426:AGG:A | donor_loss | 1.0000 |
| 10:102854427:GG:G | donor_loss | 1.0000 |
| 10:102854427:GGT:G | donor_loss | 1.0000 |
| 10:102854428:G:A | donor_loss | 1.0000 |
| 10:102854428:G:C | donor_loss | 1.0000 |
| 10:102854429:T:G | donor_loss | 1.0000 |
| 10:102854436:G:GT | donor_gain | 1.0000 |
| 10:102854466:G:T | donor_gain | 1.0000 |
| 10:102860330:A:AG | acceptor_gain | 1.0000 |
| 10:102860330:AGCT:A | acceptor_gain | 1.0000 |
| 10:102860331:G:GT | acceptor_gain | 1.0000 |
| 10:102860331:GC:G | acceptor_gain | 1.0000 |
| 10:102860331:GCT:G | acceptor_gain | 1.0000 |
| 10:102860331:GCTG:G | acceptor_gain | 1.0000 |
| 10:102860331:GCTGC:G | acceptor_gain | 1.0000 |
| 10:102860390:AAGAT:A | donor_gain | 1.0000 |
| 10:102860391:AGAT:A | donor_gain | 1.0000 |
| 10:102860392:G:GT | donor_gain | 1.0000 |
| 10:102860392:GAT:G | donor_gain | 1.0000 |
| 10:102860392:GATG:G | donor_gain | 1.0000 |
| 10:102860392:GATGT:G | donor_loss | 1.0000 |
| 10:102860393:AT:A | donor_gain | 1.0000 |
| 10:102860394:TGTA:T | donor_loss | 1.0000 |
| 10:102860394:TGTAA:T | donor_loss | 1.0000 |
| 10:102860395:G:GC | donor_loss | 1.0000 |
| 10:102860395:G:GG | donor_gain | 1.0000 |
| 10:102860396:T:G | donor_loss | 1.0000 |
| 10:102860496:A:AG | acceptor_gain | 1.0000 |
| 10:102860497:G:GG | acceptor_gain | 1.0000 |
| 10:102860497:GA:G | acceptor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000351567 (10:102859129 TCTC>T), RS1000390019 (10:102862471 G>A), RS1000471832 (10:102853544 C>T), RS1000955352 (10:102857236 C>T), RS1001252651 (10:102856628 A>T), RS1001317811 (10:102853650 A>G), RS1001327257 (10:102860186 T>C), RS1001620289 (10:102857005 T>G), RS1002118662 (10:102852517 G>A,C), RS1002171220 (10:102852832 T>C), RS1002200013 (10:102852314 A>C), RS1002202384 (10:102858286 G>A), RS1002221535 (10:102858519 A>G), RS1002429092 (10:102865292 A>C), RS1002951538 (10:102854455 T>G)
Disease associations
OMIM: gene MIM:616600 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
25 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000528_8 | Parkinson’s disease | 7.000000e-08 |
| GCST001421_1 | Arsenic metabolism | 3.000000e-09 |
| GCST001942_1 | Prostate cancer | 5.000000e-10 |
| GCST002149_2 | Schizophrenia | 4.000000e-13 |
| GCST002539_4 | Schizophrenia | 6.000000e-19 |
| GCST003253_11 | Microalbuminuria | 6.000000e-06 |
| GCST004258_2 | Diastolic blood pressure (long-term average) | 8.000000e-09 |
| GCST004259_3 | Mean arterial pressure (long-term average) | 1.000000e-11 |
| GCST004521_172 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_78 | Autism spectrum disorder or schizophrenia | 1.000000e-16 |
| GCST004904_25 | Body mass index | 5.000000e-11 |
| GCST004946_77 | Schizophrenia | 4.000000e-17 |
| GCST004946_86 | Schizophrenia | 4.000000e-20 |
| GCST005956_50 | Waist-to-hip ratio adjusted for BMI | 8.000000e-06 |
| GCST005958_15 | Waist-to-hip ratio adjusted for BMI (age >50) | 4.000000e-06 |
| GCST006231_42 | Mean arterial pressure | 2.000000e-11 |
| GCST006803_4 | Schizophrenia | 7.000000e-18 |
| GCST007603_17 | Smoking initiation | 2.000000e-13 |
| GCST007705_26 | Pulse pressure | 2.000000e-11 |
| GCST007707_64 | Hypertension | 4.000000e-10 |
| GCST009600_45 | Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | 3.000000e-16 |
| GCST009703_5 | Arsenic metabolism | 2.000000e-09 |
| GCST010703_271 | Brain morphology (MOSTest) | 5.000000e-13 |
| GCST012354_36 | Anxiety | 4.000000e-06 |
| GCST90002403_228 | Red blood cell count | 5.000000e-16 |
EFO canonical traits (10, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004880 | urinary arsenic measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006340 | mean arterial pressure |
| EFO:0004340 | body mass index |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0005670 | smoking initiation |
| EFO:0005763 | pulse pressure measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0009863 | anxiety measurement |
| EFO:0004305 | erythrocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, decreases metabolic processing | 2 |
| Valproic Acid | affects expression, decreases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Demecolcine | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Vincristine | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_SF96 | HAP1 C10orf32 (-) 1 | Cancer cell line | Male |
| CVCL_SF97 | HAP1 C10orf32 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.